0002138882-26-000003.txt : 20261110 0002138882-26-000003.hdr.sgml : 20261110 20261110154410 ACCESSION NUMBER: 0002138882-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261110 DATE AS OF CHANGE: 20261110 EFFECTIVENESS DATE: 20261110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chickadee Biomedicines, Inc. CENTRAL INDEX KEY: 0002138882 ORGANIZATION NAME: EIN: 394768459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-604283 FILM NUMBER: 261540021 BUSINESS ADDRESS: STREET 1: 626 1ST AVENUE STREET 2: #W26H CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 929-385-7512 MAIL ADDRESS: STREET 1: 91 OAKMERE STREET CITY: BOSTON STATE: MA ZIP: 02132-5529 D 1 primary_doc.xml X0708 D LIVE 0002138882 Chickadee Biomedicines, Inc. 626 1ST AVENUE #W26H NEW YORK NY NEW YORK 10016 929-385-7512 DELAWARE None None Corporation true 2025 Weining Lu 91 Oakmere Street Boston MA MASSACHUSETTS 02132 Executive Officer Director Promoter Goran Mikael Dolsten 7 Rochambeau Road Scarsdale NY NEW YORK 10583 Executive Officer Director Promoter Patrick James Doyle 626 1st Avenue #W26H New York NY NEW YORK 10016 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-10-28 false true true true Simple Agreements for Future Equity (SAFEs) and Issuer's equity securities that would be issued upon conversion of SAFEs false 0 1000000 1000000 0 false 2 0 0 0 true Proceeds will be used for Issuer's general corporate and working capital purposes, which will include payment of salary of executive officer in the ordinary course of business as disclosed to investors. false Chickadee Biomedicines, Inc. /s/ Patrick Doyle Patrick J. Doyle Chief Executive Officer 2026-11-10